The Safety of Glucosodiene on an In-Vitro Biopsy Cell Line Model.

This manuscript explores the safety and potential efficacy of glucosodiene, an isomeric alkaline glucose compound, as a therapeutic agent for cancer treatment. The study focuses on conducting safety tests using BJ1 cells (Normal Skin Fibroblasts) and evaluates the cytotoxic effects of glucosodiene on these cells. The results indicate that glucosodiene, at a concentration of 100 ppm, does not exhibit toxicity or impair normal cellular functions. These findings suggest that the compound may selectively target tumor cells without affecting healthy cells. However, further research is needed to understand the mechanisms of action and confirm its efficacy.